These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25563018)

  • 1. [Problems of depressive insomnia].
    Tarakanova EA; Ivanchuk ÉG; Rostovshchikov VV
    Vestn Ross Akad Med Nauk; 2014; (7-8):153-7. PubMed ID: 25563018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major depressive disorder, anhedonia and agomelatine: an open-label study.
    Di Giannantonio M; Di Iorio G; Guglielmo R; De Berardis D; Conti CM; Acciavatti T; Cornelio M; Martinotti G
    J Biol Regul Homeost Agents; 2011; 25(1):109-14. PubMed ID: 21382280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.
    Kasper S; Hajak G; Wulff K; Hoogendijk WJ; Montejo AL; Smeraldi E; Rybakowski JK; Quera-Salva MA; Wirz-Justice AM; Picarel-Blanchot F; Baylé FJ
    J Clin Psychiatry; 2010 Feb; 71(2):109-20. PubMed ID: 20193645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agomelatine: a novel mechanism of antidepressant action involving the melatonergic and the serotonergic system.
    San L; Arranz B
    Eur Psychiatry; 2008 Sep; 23(6):396-402. PubMed ID: 18583104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of resistant insomnia and major depression.
    Vellante F; Cornelio M; Acciavatti T; Cinosi E; Marini S; Dezi S; De Risio L; Di Iorio G; Martinotti G; Di Giannantonio M
    Clin Ter; 2013; 164(5):429-35. PubMed ID: 24217831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subgroup analysis of the non-interventional study VIVALDI: agomelatine in treatment-naïve patients, in combination therapy and after treatment switch.
    Laux G; Huttner NA;
    Int J Psychiatry Clin Pract; 2014 Jun; 18(2):86-96. PubMed ID: 24506342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin agonists and insomnia.
    Ferguson SA; Rajaratnam SM; Dawson D
    Expert Rev Neurother; 2010 Feb; 10(2):305-18. PubMed ID: 20136385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agomelatine as chronopsychopharmaceutics restoring circadian rhythms and enhancing resilience to stress: a wishfull thinking or an innovative strategy for superior management of depression?
    Jakovljević M
    Psychiatr Danub; 2011 Mar; 23(1):2-9. PubMed ID: 21448091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experience of the use of agomelatine in the treatment of patients with depression and chronic brain ischemia].
    Antonen EG; Nikitina MV; Kruchek MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):79-85. PubMed ID: 26978498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study.
    Stein DJ; Ahokas AA; de Bodinat C
    J Clin Psychopharmacol; 2008 Oct; 28(5):561-6. PubMed ID: 18794654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.
    Kasper S; Hamon M
    World J Biol Psychiatry; 2009; 10(2):117-26. PubMed ID: 19255935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
    Zajecka J; Schatzberg A; Stahl S; Shah A; Caputo A; Post A
    J Clin Psychopharmacol; 2010 Apr; 30(2):135-44. PubMed ID: 20520286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?
    Srinivasan V; Brzezinski A; Pandi-Perumal SR; Spence DW; Cardinali DP; Brown GM
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):913-23. PubMed ID: 21453740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agomelatine in the treatment of seasonal affective disorder.
    Pjrek E; Winkler D; Konstantinidis A; Willeit M; Praschak-Rieder N; Kasper S
    Psychopharmacology (Berl); 2007 Mar; 190(4):575-9. PubMed ID: 17171557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial.
    Goodwin GM; Emsley R; Rembry S; Rouillon F;
    J Clin Psychiatry; 2009 Aug; 70(8):1128-37. PubMed ID: 19689920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonergic drugs in clinical practice.
    Hardeland R; Poeggeler B; Srinivasan V; Trakht I; Pandi-Perumal SR; Cardinali DP
    Arzneimittelforschung; 2008; 58(1):1-10. PubMed ID: 18368944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability.
    Ballester P; Martínez MJ; Inda MD; Javaloyes A; Richdale AL; Muriel J; Belda C; Toral N; Morales D; Fernández E; Peiró AM
    J Psychopharmacol; 2019 Nov; 33(11):1395-1406. PubMed ID: 31423939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The results of the Russian multicenter open observational non-comparative study on the efficacy and safety of valdoxan (agomelatin) in the treatment of patients with major depressive disorder and insomnia (the VIVALDI study)].
    Poluéktov MG; Levin YI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):39-44. PubMed ID: 24430033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders].
    Lôo H; Daléry J; Macher JP; Payen A
    Encephale; 2003; 29(2):165-71. PubMed ID: 14567168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo-controlled trial of agomelatine in the treatment of major depressive disorder.
    Kennedy SH; Emsley R
    Eur Neuropsychopharmacol; 2006 Feb; 16(2):93-100. PubMed ID: 16249073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.